Advisors Preferred, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Advisors Preferred, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$62.15 - $90.32 $1.19 Million - $1.73 Million	-19,194 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$61.35 - $90.47 $1.18 Million - $1.74 Million	19,194 New	19,194 $1.29 Million
Q4 2019 Jan 21, 2020	SELL	$28.14 - $73.01 $11,818 - $30,664	-420 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $11,029 - $14,641	420 New	420 $12,000

306

95.9M

523K

493K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.